Decheng Capital Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Decheng Capital Llc disclosed 14 stock positions valued at approximately $731.75M as of quarter-end June 30, 2026. The largest holdings include CG ONCOLOGY INC, Nuvation Bio Inc., and AARDVARK THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 14
- Portfolio Value
- $731.75M
Holdings by Sector
Decheng Capital Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | CGON | Healthcare | 61.87% | 6,371,669 | - | - | $452,707,083 |
| Nuvation Bio Inc. | NUVB | Healthcare | 20.15% | 25,954,439 | - | - | $147,421,214 |
| AARDVARK THERAPEUTICS INC | AARD | Other | 3.08% | 3,917,299 | - | - | $22,563,642 |
| Aclaris Therapeutics, Inc. | ACRS | Healthcare | 2.92% | 4,041,736 | - | - | $21,380,783 |
| Upstream Bio Inc. | UPB | Other | 2.58% | 2,724,868 | - | - | $18,856,087 |
| Arcus Biosciences, Inc | RCUS | Healthcare | 1.96% | 464,779 | -13,040 | -2.73% | $14,329,137 |
| Equillium Inc. | EQ | Healthcare | 1.94% | 4,447,308 | - | - | $14,231,386 |
| REVOLUTION MEDICINES INC(NSM) | RVMD | Healthcare | 1.35% | 52,667 | -40,833 | -43.67% | $9,863,476 |
| Lyell Immunopharma, Inc. | LYEL | Healthcare | 1.33% | 692,050 | - | - | $9,723,303 |
| BeyondSpring Inc. | BYSI | Other | 0.91% | 3,800,702 | - | - | $6,651,229 |
| Zentalis Pharmaceuticals Inc. | ZNTL | Healthcare | 0.88% | 1,323,327 | - | - | $6,418,136 |
| NEWAMSTERDAM PHARMA CO NV | NAMSW | Other | 0.82% | 176,887 | -148,170 | -45.58% | $5,994,700 |
| Pyxis Oncology, Inc (formerly Apexigen) | PYXS | Healthcare | 0.13% | 326,810 | - | - | $983,698 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 0.09% | 20,000 | +20,000 | +100.00% | $625,200 |
Showing 14 of 14 holdings in the latest reporting period.